RedHill Biopharma Ltd. (RDHL)

6.25
0.10 1.63
NASDAQ : Health Technology
Prev Close 6.15
Open 6.17
Day Low/High 6.10 / 6.33
52 Wk Low/High 5.13 / 9.20
Volume 96.49K
Avg Volume 268.60K
Exchange NASDAQ
Shares Outstanding 35.27M
Market Cap 220.47M
EPS -1.70
P/E Ratio 36.47
Div & Yield N.A. (N.A)

Latest News

How I Invest In Biotech Stocks

How I Invest In Biotech Stocks

Here's two 'rules of the road' when investing in this highly volatile space.

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

3 Small Biotechs That Still Have Upside

3 Small Biotechs That Still Have Upside

Companies developing drugs for cancer, eye problems and pets -- offer untapped value.

One Small Pharma Stock Has Big Potential

One Small Pharma Stock Has Big Potential

Redhill has some promising drugs in its pipeline, and is well funded.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

These 5 stocks all have positive catalysts on the horizon.